UCL Business

Trusted

http://www.uclb.com/e-lucid-customers

Last activity: 16.09.2026

Active

Categories: BusinessCollegeEconomyEnterpriseFinTechIndustryITSocietyTechnologyUniversity

UCL Business Ltd (UCLB) is the technology commercialisation company of

@ucl |

@ucltf fund for UCL academics | member of TenU

@TenU_News

Twitter LinkedIn Email

Followers

1.37K

Website visits

7.8K /mo.

Mentions

Persons

Overview

Founded date

1993

Persons 4

Date	First Name	Last Name	Title	LinkedIn	Twitter	Email	Location
Sign up to see	Sign up to see	Sign up to see	Sign up to see	Sign up to see	Sign up to see	Sign up to see	Sign up to see
	Anne	Lane	Interim Managing Director	LinkedIn		Sign up to see
	Steven	Schooling	Director, Engineering and Physical Sciences	LinkedIn		Sign up to see
	Richard	Fagan	Director of BioPharm	LinkedIn		Sign up to see

Mentions in press and media 19

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Jun 3, 2026	Gigaton lands $26M to scale autonomous industrial control	Gigaton, a London-based AI company developing control software for energy-intensive industries, has raised $26 million in Series A funding. The round was led by Plural, with participation from 2150, Semapa Next, and existing investors Plane...
May 12, 2026	Scotland’s Spinout Potential Is Real – And Its Capital Is Finally Catching Up	University Spinouts are having a moment. Investment in the sector hit £3.35bn in 2024, up 44% on the year before, and the institutions driving those headlines – UCL, Oxford, Cambridge – are clustered within a few miles of each other in Lond...
Mar 6, 2026	University spinouts boom as startups pull in billions	Academics are increasingly going on to start their own start-ups, with a surge in spinouts, patents and investment pointing to the growing commercial impact of Britain’s research base. New figures seen by City AM show the number of UCL acad...
Dec 15, 2025	EpilepsyGTx Secures $33M to Pioneer Single-Dose Gene Therapy for Refractory Epilepsy	EpilepsyGTx just raised $33 million. This Series A funding will fuel clinical trials. Their focus? A gene therapy for focal refractory epilepsy (FRE). FRE impacts millions globally. Current treatments often fail. EpilepsyGTx offers a potent...
Dec 10, 2025	EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy	Investment from XGEN Venture, British Business Bank, and a global biopharmaceutical company will support first-in-human Phase 1/2a clinical trials for lead candidate EPY201 targeting focal refractory epilepsy (FRE) Future financings to adva...
Jun 5, 2023	Olympus acquires UK AI endoscopy company Odin Vision in ‘up to’ £66 million deal	UK-based Odin Vision, a Cloud AI endoscopy company has been acquired by Olympus Corporation (Olympus) for up to £66 million. The deal will see Olympus acquire Odin’s entire portfolio of AI solutions, giving Odin’s technology reach worldwide...
Oct 21, 2021	Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes	Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes 21-10-2021 The University of Cambridge Enterprise Fund has joined in a £1 million investment in Carbon Re, a UK climate tech start-up that uses artifici...
Jun 17, 2021	UCL, Imperial College London and University of Cambridge are behind innovative industry university collaboration receiving £100m funding to rapidly advance cutting-edge science
Jul 16, 2020	Research England backs two initiatives to boost economic value realised from university research	Research England backs two initiatives to boost economic value realised from university research 16-07-2020 Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the econ...
Jul 16, 2020	Research England backs two initiatives to boost economic value realised from university research	Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the economic value and social impacts derived from university research, both internationally and in the UK. The fund...
Sep 13, 2019	MRC’s first decade of translational research funding leads to £1.1bn private-sector investment and new therapies for patients	MRC’s first decade of translational research funding leads to £1.1bn private-sector investment and new therapies for patients 13-09-2019 A new report has found that MRC funding schemes for translational research have boosted the UK’s life s...
Dec 17, 2018	LifeArc launches Technology Transfer Fellowships	London, UK, December 17th, 2018. LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer Fellowship programme in partnership with Imperial Innovations, Queen Mary Innovation and UCL Business (UCLB), ...
Nov 30, 2018	IGEM Therapeutics Announces Final Close of £5m Series A Financing Round	IGEM Therapeutics (IGEM or “the Company”), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, announced it has secured an additional £3 million to close its Series A round at £5 million. Two new i...
Aug 1, 2018	UCL spin-out Hazy adds $1.8 million in seed funding	This takes Hazy’s total seed funding to $2.8 million following a $1 million investment from M12 and Notion, awarded to the company in May, after Hazy was declared the European winner of global startup competition Innovate.AI.
Jan 18, 2016	University College London Launches £50M Investment Fund	University College London is launching its first investment fund. Managed by Albion Ventures, the UCL Technology Fund will invest £50m in commercializing UCL’s research emerging over the next five years. It will support academics whose rese...
Jan 18, 2016	Albion to Manage the UCL Technology Fund	Albion Capital will manage and administer the Fund in partnership with UCL’s technology transfer company UCL Business, with whom it has a long-standing relationship including co-investment.
May 24, 2011	Abcodia secures £1 million funding	Abcodia secures £1 million funding 24-05-2011 Abcodia announces funding of £1 million to develop its visionary plans which could transform the way that life-threatening diseases are diagnosed. Abcodia, a company engaged in the validation an...
Mar 8, 2011	Collaborative partners sought for Abcodia, a newly launched molecular diagnostic company	Collaborative partners sought for Abcodia, a newly launched molecular diagnostic company 08-03-2011 Abcodia, a new company launched today by Cambridge biotech entrepreneurs, is seeking collaborative partners. It has been granted rights to c...

Reviews 0

FAQ about UCL Business

When was UCL Business founded?

UCL Business was founded in 1993.

What has the press written about UCL Business?

Parsers VC has collected 19 articles mentioning UCL Business, among them “Gigaton lands $26M to scale autonomous industrial control” (Jun 3, 2026) and “Scotland’s Spinout Potential Is Real – And Its Capital Is Finally Catching Up” (May 12, 2026).

Is UCL Business still active?

Yes, UCL Business is active; its latest activity on Parsers VC dates from Sep 16, 2026.